Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Xenon in Children With Autism Spectrum Disorder
NCT07435103Phase 2Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xenon in Autism Spectrum Disorder (ASD), sponsored by Children's Hospital, Zhejiang University School of Medicine. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
xenon
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07435103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07435103.